Form 4 for TVRD Tvardi Therapeutics, Inc.
Accepted 2022-06-16 00:00:00 ET · period of report 2022-06-15 · accession 0001209191-22-037523 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-16 | 2022-06-15 | TVRD | Makara Richard | VP, Head of Accting, Ctrl | A - Grant | $0.00 | +7,500 | 13.6K | +123% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-15 | A | A | 7,500 | $0.00 | 13,583 | D | — | — | (F1) Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of (i) December 31, 2022, or (ii) the appointment of the Issuer's new Chief Financial Officer, subject to the Reporting Person's continued service to the Issuer as of such vesting date. |